Stephen L. Hoffman M.D., D.T.M.H., CAPT, MC, USN (RET)
Sanaria, Inc.

Dr. Stephen Hoffman received his M.D. from Cornell University Medical
College, earned a Diploma in Tropical Medicine and Hygiene (D.T.M.H.) from the
London School of Hygiene and Tropical Medicine, and completed residency training at
the University of California, San Diego. For nearly 15 years he served as Director of the
Malaria Program at the Naval Medical Research Center, which focused on malarial
vaccine development and the genomics of Plasmodium falciparum (the malaria parasite).
After serving briefly as Senior Vice President of Biologics at Celera Genomics, Dr.
Hoffman founded Sanaria, Inc. in 2002, where he is currently CEO and Chief Scientific
Officer.

Dr. Hoffman holds several professorships and serves on multiple advisory boards.
He is a past president of the American Society of Tropical Medicine and Hygiene, has
edited two books on malaria vaccine development, has authored more than 325 scientific
publications, and holds multiple patents. He is the most frequently cited author in the
world for scientific papers on malaria published between 1995 and 2005. As of 2004, he
is an elected member of the Institute of Medicine of the National Academies.